Ameriprise’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.61M Sell
27,401
-4,387
-14% -$1.06M ﹤0.01% 2131
2025
Q1
$7.74M Sell
31,788
-2,394
-7% -$583K ﹤0.01% 1954
2024
Q4
$11.2M Buy
34,182
+571
+2% +$188K ﹤0.01% 1705
2024
Q3
$11.2M Buy
33,611
+16,910
+101% +$5.66M ﹤0.01% 1686
2024
Q2
$4.56M Buy
16,701
+4,868
+41% +$1.33M ﹤0.01% 2379
2024
Q1
$4.09M Buy
11,833
+43
+0.4% +$14.9K ﹤0.01% 2484
2023
Q4
$3.81M Sell
11,790
-408
-3% -$132K ﹤0.01% 2538
2023
Q3
$4.37M Sell
12,198
-98
-0.8% -$35.1K ﹤0.01% 2381
2023
Q2
$4.66M Sell
12,296
-2,298
-16% -$871K ﹤0.01% 2397
2023
Q1
$6.99M Buy
14,594
+2,228
+18% +$1.07M ﹤0.01% 2068
2022
Q4
$5.24M Buy
12,366
+868
+8% +$368K ﹤0.01% 2259
2022
Q3
$4.8M Sell
11,498
-594
-5% -$248K ﹤0.01% 2260
2022
Q2
$5.98M Sell
12,092
-8,839
-42% -$4.37M ﹤0.01% 2138
2022
Q1
$11.8M Sell
20,931
-47,935
-70% -$27M ﹤0.01% 1783
2021
Q4
$52M Buy
68,866
+679
+1% +$513K 0.01% 822
2021
Q3
$51M Sell
68,187
-32,055
-32% -$24M 0.02% 768
2021
Q2
$64.6M Buy
100,242
+8,761
+10% +$5.64M 0.02% 679
2021
Q1
$52.2M Sell
91,481
-74,716
-45% -$42.7M 0.02% 753
2020
Q4
$96.9M Sell
166,197
-2,218
-1% -$1.29M 0.03% 485
2020
Q3
$86.8M Sell
168,415
-17,496
-9% -$9.02M 0.04% 466
2020
Q2
$83.9M Sell
185,911
-31,097
-14% -$14M 0.04% 439
2020
Q1
$76.1M Buy
217,008
+151,358
+231% +$53.1M 0.04% 416
2019
Q4
$24.2M Buy
65,650
+6,286
+11% +$2.32M 0.01% 1045
2019
Q3
$19.8M Buy
59,364
+567
+1% +$189K 0.01% 1152
2019
Q2
$18.4M Sell
58,797
-1,650
-3% -$516K 0.01% 1232
2019
Q1
$18.5M Sell
60,447
-1,189
-2% -$363K 0.01% 1201
2018
Q4
$14.3M Sell
61,636
-3,842
-6% -$892K 0.01% 1302
2018
Q3
$20.5M Sell
65,478
-1,463
-2% -$458K 0.01% 1274
2018
Q2
$19.3M Buy
66,941
+767
+1% +$221K 0.01% 1204
2018
Q1
$16.5M Buy
66,174
+431
+0.7% +$108K 0.01% 1263
2017
Q4
$15.7M Buy
65,743
+3,713
+6% +$886K 0.01% 1253
2017
Q3
$13.8M Sell
62,030
-7,414
-11% -$1.65M 0.01% 1328
2017
Q2
$15.7M Buy
69,444
+450
+0.7% +$102K 0.01% 1201
2017
Q1
$13.8M Sell
68,994
-2,447
-3% -$488K 0.01% 1284
2016
Q4
$13M Buy
71,441
+7,320
+11% +$1.33M 0.01% 1308
2016
Q3
$10.5M Buy
64,121
+8,820
+16% +$1.44M 0.01% 1399
2016
Q2
$7.91M Buy
55,301
+1,627
+3% +$233K ﹤0.01% 1587
2016
Q1
$7.34M Sell
53,674
-62,718
-54% -$8.58M ﹤0.01% 1676
2015
Q4
$16.1M Sell
116,392
-8,483
-7% -$1.18M 0.01% 1076
2015
Q3
$16.8M Sell
124,875
-28,485
-19% -$3.83M 0.01% 1060
2015
Q2
$23.1M Sell
153,360
-10,144
-6% -$1.53M 0.01% 909
2015
Q1
$22.1M Buy
163,504
+6,277
+4% +$849K 0.01% 940
2014
Q4
$19M Buy
157,227
+16,310
+12% +$1.97M 0.01% 1002
2014
Q3
$16M Buy
140,917
+4,937
+4% +$560K 0.01% 1103
2014
Q2
$16.3M Sell
135,980
-714
-0.5% -$85.5K 0.01% 1180
2014
Q1
$17.5M Buy
136,694
+75,149
+122% +$9.63M 0.01% 1094
2013
Q4
$7.61M Buy
61,545
+377
+0.6% +$46.6K ﹤0.01% 1698
2013
Q3
$7.19M Buy
61,168
+2,936
+5% +$345K ﹤0.01% 1689
2013
Q2
$6.53M Buy
+58,232
New +$6.53M ﹤0.01% 1721